Venous Thromboembolism Following Caesarean delivery
Conditions
Interventions
Control group (received the routine nursing care):None
Early warning group (received the early-warnig nursing care):None
Sponsors
Women’s Hospital of Nanjing Medical University, Nanjing Maternity and Child Health Care Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: Pregnant women (age =18 years old) who underwent either emergency or elective caesarean delivery between January 1, 2020 to October 30, 2023 were screened for enrolment.
Exclusion criteria
Exclusion criteria: Participants who reported history of the previous adverse effects with unfractionated heparin (UFH) or low molecular weight heparin (LMWH) including Heparin-Induced Thrombocytopenia (HIT), signs, or symptoms of venous thrombosis, severe renal and/or hepatic impairment, malignancy, high risk of bleeding and/or receiving warfarin, did not stay at least two nights as in-participants postoperatively were excluded. Cases with incomplete medical records or follow-up data were also not considered eligible to the present study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| incidence of symptomatic VTE following CD ; | — |
Secondary
| Measure | Time frame |
|---|---|
| correct rates of VTE risk assessment ;rates of mechanical or pharmacologic prophylaxis receipts for VTE;incidence of side effects; | — |
Countries
China
Contacts
Public ContactBichao Wang
Women’s Hospital of Nanjing Medical University, Nanjing Maternity and Child Health Care Hospital
Outcome results
None listed